Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 15, 2026
PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX): A Rules-Based Approach to Developed Markets ex-U.S.

PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX): A Rules-Based Approach to Developed Markets ex-U.S.

Key Takeaways

  • MFDX provides diversified exposure to developed-market equities outside the United States through a rules-based, multi-factor strategy emphasizing value, quality, momentum, low volatility, and size factors.
  • The ETF held approximately 1,300 securities as of mid-2026, with the largest country allocations to Japan, the United Kingdom, Canada, and Switzerland, and top sector weights in industrials and financial services.
  • International developed-market equities have benefited from improving earnings momentum and attractive relative valuations compared to U.S. peers, though geopolitical tensions and energy price volatility have introduced intermittent headwinds.
  • MFDX's multi-factor design and broad diversification across countries and sectors provide a structurally resilient foundation, though the fund remains sensitive to currency fluctuations and shifts in global monetary policy.
  • Investor attention to AI-driven capital expenditure cycles, central bank rate trajectories, and energy supply dynamics will be critical in shaping the fund's performance environment through the remainder of 2026.

Overview of the MFDX ETF

Launched in August 2017 and managed by PIMCO, the PIMCO RAFI Dynamic Multi-Factor International Equity ETF seeks to track the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The fund invests at least 80% of its total assets in the component securities of the underlying index, which is constructed using a rules-based methodology that dynamically allocates across five factor portfolios: value, low volatility, quality, momentum, and size. This smart-beta approach aims to capture excess returns while potentially reducing risk relative to less diversified strategies.

MFDX maintains a broadly diversified portfolio of approximately 1,300 holdings, with the top 10 positions accounting for roughly 8.8% of total assets — reflecting a low-concentration structure. The largest individual holdings include ASML Holding N.V., Novartis AG, Tokyo Electron Limited, Banco Santander S.A., Nestlé S.A., and Roche Holding AG. Sector allocations are led by industrials at roughly 19%, followed by financial services at approximately 16%, basic materials around 10%, and technology near 10%. Geographically, Japan represents the largest country exposure at about 26%, with the United Kingdom, Canada, Switzerland, France, and Germany rounding out the top exposures. The fund carries a net expense ratio of 0.39% and reported total net assets of approximately $456 million as of mid-2026. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the international equity space.

The Industry and Thematic Landscape

Developed international equity markets have navigated a complex environment through the first half of 2026. The global expansion has remained on solid footing, supported by resilient consumer spending and a powerful AI-driven capital expenditure cycle. However, geopolitical tensions — particularly the U.S.-Israeli military campaign against Iran and the effective closure of the Strait of Hormuz — have disrupted energy markets, pushed up inflation expectations, and forced markets to reassess the policy path for major central banks.

Against this backdrop, non-U.S. equities have attracted renewed attention from institutional allocators. Several factors underpin this interest: attractive relative valuations compared to U.S. stocks, improving earnings momentum across Europe and Japan, and a broadening of the global equity rally beyond U.S. large-cap technology names. Japan's ongoing corporate governance reforms continue to unlock shareholder value, while European defense spending commitments have brightened the region's long-term growth outlook. At the same time, persistent inflation and the possibility of additional monetary tightening by developed-market central banks have introduced periodic risk-off episodes, affecting international equity ETFs including MFDX.

Performance and Positioning Snapshot

MFDX has exhibited relatively range-bound behavior in recent months, reflecting the tug-of-war between supportive earnings trends and macroeconomic uncertainty. The fund's multi-factor design — blending value, quality, and low-volatility exposures — has provided a degree of downside cushion during risk-off episodes while still capturing upside participation during broad-based rallies in developed international markets.

The fund's heavy weighting toward industrials and financial services means it remains levered to global economic growth and capital expenditure trends. Holdings in semiconductor equipment leaders such as ASML and Tokyo Electron have benefited from the AI infrastructure buildout, while positions in European financials like Banco Santander and Societe Generale have been supported by a higher-for-longer interest rate environment. Conversely, the fund's exposure to basic materials and energy — through names like Glencore and Rio Tinto — has introduced sensitivity to commodity price fluctuations, which have been particularly volatile amid the Middle East energy supply disruption. Currency dynamics, especially the yen and euro against the U.S. dollar, have also influenced the ETF's performance, given that MFDX does not hedge its currency exposure.

Enhancing Analysis with AI Tools

For investors seeking to identify new opportunities across global equity markets, Tickeron's AI Screener provides an AI-powered stock and ETF discovery platform. The tool enables users to scan thousands of securities using a comprehensive range of criteria including technical indicators, fundamental metrics, volatility measures, AI-generated signals, market trends, price patterns, and customizable industry filters. By automating the screening process, the AI Screener helps investors surface trending securities, breakout candidates, and new trading ideas more efficiently than manual research alone. I find it particularly useful when monitoring multi-factor international ETFs like MFDX or exploring individual stock opportunities alongside broader market themes. The platform offers a streamlined approach to idea generation that complements traditional fundamental work.

2026 Outlook and Key Factors to Monitor

Looking ahead, several structural factors will likely influence MFDX's investment environment. The trajectory of global monetary policy remains front and center: with the Federal Reserve expected to remain on hold while other developed-market central banks navigate sticky inflation, the interest rate differential between the U.S. and other economies will continue to shape currency markets — a critical variable for an unhedged international equity fund.

The AI capex supercycle represents a powerful tailwind for MFDX's technology and industrial holdings, particularly the fund's exposure to semiconductor equipment manufacturers and industrial automation companies. However, the durability of this spending cycle and its ultimate return on investment will be closely scrutinized by markets. Additionally, the potential for a weakening U.S. dollar — cited by several major research institutions as a core conviction for the second half of 2026 — could provide a meaningful boost to unhedged international equity returns.

On the risk side, an escalation or prolonged duration of the Middle East energy supply disruption could dampen global growth, pressure corporate margins in energy-sensitive sectors, and reignite inflation concerns — all of which would challenge international equity performance. Japan's evolving monetary policy stance, given the fund's substantial allocation to Japanese equities, also warrants close monitoring. Finally, as international equities continue to attract capital flows, the competitive landscape among international equity ETFs may intensify, making MFDX's factor-based methodology and expense ratio important differentiators for cost-conscious investors.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MFDX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for MFDX turns positive, indicating new upward trend

MFDX saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MFDX just turned positive on July 30, 2026. Looking at past instances where MFDX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

MFDX moved above its 50-day moving average on July 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MFDX crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MFDX advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 327 cases where MFDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MFDX moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MFDX broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), BHP Group Limited (NYSE:BHP), Shopify Inc (NASDAQ:SHOP), Boeing Company (NYSE:BA), AT&T (NYSE:T), Medtronic plc (NYSE:MDT), BP plc (NYSE:BP), Spotify Technology SA (NYSE:SPOT), Suncor Energy (NYSE:SU).

Industry description

The investment seeks to track the investment results of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The fund seeks to achieve its investment objective by investing at least 80% of its total assets (exclusive of collateral held from securities lending) in the component securities of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The underlying index is constructed by the index provider using a rules-based approach to construct factor portfolios within the underlying index. The underlying index consists of "factor portfolios," each of which emphasizes one of the following factors: value, low volatility, quality, momentum and size.

Market Cap

The average market capitalization across the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF is 40.85B. The market cap for tickers in the group ranges from 989.57K to 694.76B. ASML holds the highest valuation in this group at 694.76B. The lowest valued company is ANDR at 989.57K.

High and low price notable news

The average weekly price growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was 1%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 3%. ARX experienced the highest price growth at 59%, while BAER experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was -0% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 57
Price Growth Rating: 49
SMR Rating: 62
Profit Risk Rating: 63
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
MFDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Details
Category
Foreign Large Blend
Address
PIMCO Equity Series650 Newport Center DriveNewport Beach
Phone
N/A
Web
www.pimco.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.